← Open Payments lookup

CHRISTIAN TAKAYAMA: Open Payments

NPI 1992968648 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,811 in 66 payments from 6 companies in 2025. Trend: 2023 $1,722 · 2024 $2,212 · 2025 $1,811

Food & beverage: $1,811
CompanyPaymentsAmount
Gilead Sciences, Inc.35$1,007
ViiV Healthcare Company16$414
Merck Sharp & Dohme LLC7$175
Napo Pharmaceuticals Inc4$103
ABBVIE INC.3$87
GlaxoSmithKline, LLC.1$24

Products named: CABENUVA, PIFELTRO, APRETUDE, Mytesi, Biktarvy, MAVYRET, DOVATO, GARDASIL 9.

Industry payments across CA — which companies pay providers there.